In the wet and windy middle of May, Bio/Technology editors Douglas McCormick and Bernard Dixon journeyed to the Wembley convention center, outside London. Over dinner, they met with seven prominent executives and researchers for a frank discussion of the state and prospects of biotechnology in Europe.
